Screener
Eligibility screening
Neoadjuvant Lu-177-PSMA-617 in Patients With High Risk Localized Prostate Cancer Undergoing Radical Prostatectomy
3 US sites in DC, NJ
Before we begin
Who are you filling this out for?
Your answer affects how the questions are phrased.